RGAGX
Price
$78.43
Change
-$0.94 (-1.18%)
Updated
Jun 13 closing price
Net Assets
306.22B
USLYX
Price
$69.24
Change
-$1.13 (-1.61%)
Updated
Jun 13 closing price
Net Assets
2.05B
Interact to see
Advertisement

RGAGX vs USLYX

Header iconRGAGX vs USLYX Comparison
Open Charts RGAGX vs USLYXBanner chart's image
American Funds Growth Fund of Amer R6
Price$78.43
Change-$0.94 (-1.18%)
VolumeN/A
Net Assets306.22B
JHancock U.S. Global Leaders Growth R2
Price$69.24
Change-$1.13 (-1.61%)
VolumeN/A
Net Assets2.05B
RGAGX vs USLYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGAGX vs. USLYX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGAGX is a StrongBuy and USLYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 306B vs. USLYX (2.05B). RGAGX pays higher dividends than USLYX: RGAGX (0.65) vs USLYX (0.00). RGAGX was incepted earlier than USLYX: RGAGX (16 years) vs USLYX (13 years). USLYX (1.28) is less costly to investors than RGAGX (0.30). USLYX is a more actively managed with annual turnover of: 29.00 vs. RGAGX (25.00). USLYX has a lower initial minimum investment than RGAGX: USLYX (0) vs RGAGX (250). RGAGX annual gain was more profitable for investors over the last year : 7.67 vs. USLYX (-3.75). RGAGX return over 5 years is better than : 51.11 vs. USLYX (17.54).
RGAGXUSLYXRGAGX / USLYX
Total Expense Ratio0.301.2724%
Annual Report Gross Expense Ratio0.301.2823%
Fund Existence16 years13 years-
Gain YTD5.2050.815638%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets306B2.05B14,934%
Annual Yield % from dividends0.650.00-
Returns for 1 year7.67-3.75-204%
Returns for 3 years54.6638.59142%
Returns for 5 years51.1117.54291%
Returns for 10 years75.6257.76131%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLS1.660.01
+0.61%
SELLAS Life Sciences Group
INDV13.89-0.04
-0.29%
Indivior PLC
SMMT19.78-0.38
-1.88%
Summit Therapeutics
AQB0.81-0.02
-2.73%
AquaBounty Technologies
VREX8.19-0.34
-3.99%
Varex Imaging Corp